Tanabe K et al. — Changes in the Gene Expression in Mouse Astrocytes Induced by Pulsed Radiofrequency: A Preliminary Study
Neuroscience Letters, 2021
This Japanese in vitro study examined how PRF affects gene expression in astrocytes — the glial cells that play a central role in neuroinflammation and neuropathic pain. Mouse astrocyte cell lines were exposed to PRF (480 kHz, 20 ms pulses, 45V, 30 min) and subsequently analyzed using microarray technology covering over 56,000 probes.
Key findings:
- PRF significantly altered expression of 2,637 genes, with the effect heavily skewed toward upregulation (2,431 genes up vs. 209 down)
- 435 genes were upregulated more than 10-fold; none were downregulated to that degree — suggesting PRF activates rather than suppresses cellular activity
- Gene Ontology analysis showed that 20 out of 24 significantly enriched biological functions were immune response-related
- KEGG pathway analysis identified 7 pathways linked to neuropathic pain, with key signaling cascades (TLR, JAK-STAT, PI3K-Akt, MAPK) all activated
- Within the TLR pathway specifically, genes with anti-inflammatory and antiviral functions were strongly upregulated, while pro-inflammatory gene increases were comparatively modest
- Neurotrophic factors and anti-inflammatory cytokines (IL-4, IL-10, TGF) were also slightly but significantly increased
Proposed mechanism: PRF acts as an immunomodulator of astrocytes — and potentially of other CNS cells including microglia and neurons — primarily through the TLR signaling pathway, shifting the cellular environment toward an anti-inflammatory, neuroregenerative state.
Significance: This study provides molecular-level evidence that PRF's pain-relieving effects involve active neuroimmunomodulation, not merely nerve disruption. It adds a genomic layer of support to the broader RedoxPRF mechanistic framework, and is cited directly in the Sluijter et al. 2023 hypothesis paper.